Marian G. Sawerus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marian G. Sawerus has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Olfat Shehata
Department of Clinical Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt
5 shared publicationsEmad A. Mahdi
Department of Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt
4 shared publicationsHamdy H. Kamel
Department of Clinical Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt
4 shared publicationsWalaa M.S. Ahmed
Department of Clinical Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt
3 shared publicationsDalia EL Amir
Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt
2 shared publicationsDalia El Amir
Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
2 shared publications
Latest Publications
- Open Access
- 27 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 13522
Anti-trypanosomal, anti-inflammatory, and neuroprotective effects of Cichorium intybus sesquiterpene lactones in experimental Trypanosoma evansi infection
Trypanosoma evansi is an important protozoan pathogen affecting various animal species particularly camels and horses, leading to significant economic losses. The ineffective control of T. evansi is attributed to the absence of vaccines and emergence of resistance towards existing chemotherapeutic agents. This study evaluated the efficacy of a fraction enriched with sesquiterpene lactones derived from Cichorium intybus on parasitemia levels and related pathological changes in Trypanosoma evansi -infected rats. Eighty healthy male albino rats were allocated into four groups of equal size; Group I served as the control negative (uninfected). Group II received an intraperitoneal infection with Trypanosoma evansi (1 × 10⁴ trypanosomes/rat). Group III was also infected and received intramuscular treatment with diminazene aceturate (7 mg/kg body weight). Group IV administered a daily oral dose of C. intybus fraction (200 mg/kg body weight) and similarly infected. Infection by T. evansi induced anemia (normocytic normochromic), leucocytosis, alterations in lipid profile, and hypoglycemia. Furthermore, the infection resulted in the upregulation of interleukin-1β (IL-1β) and interleukin-6 (IL-6), alongside the downregulation of transforming growth factor-beta (TGF-β) and interleukin-10 (IL-10) gene expression levels. The pathological lesions in the splenic and brain tissues, coupled with a significant increase in brain acetylcholinesterase (AChE) activity and oxidative stress, were also observed in the infected groups. Cichorium intybus fraction administration significantly reduced the parasitemia level and alleviated the pathological changes caused by T. evansi compared to the untreated infected group. The sesquiterpene lactones- enriched fraction from C. intybus demonstrates a notable anti-trypanosomal efficacy and may represent a promising source for the development of novel trypanocidal compounds.
- 27 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 13522
Open AccessAnti-trypanosomal, anti-inflammatory, and neuroprotective effects of Cichorium intybus sesquiterpene lactones in experimental Trypanosoma evansi infection
Trypanosoma evansi is an important protozoan pathogen affecting various animal species particularly camels and horses, leading to significant economic losses. The ineffective control of T. evansi is attributed to the absence of vaccines and emergence of resistance towards existing chemotherapeutic agents. This study evaluated the efficacy of a fraction enriched with sesquiterpene lactones derived from Cichorium intybus on parasitemia levels and related pathological changes in Trypanosoma evansi -infected rats. Eighty healthy male albino rats were allocated into four groups of equal size; Group I served as the control negative (uninfected). Group II received an intraperitoneal infection with Trypanosoma evansi (1 × 10⁴ trypanosomes/rat). Group III was also infected and received intramuscular treatment with diminazene aceturate (7 mg/kg body weight). Group IV administered a daily oral dose of C. intybus fraction (200 mg/kg body weight) and similarly infected. Infection by T. evansi induced anemia (normocytic normochromic), leucocytosis, alterations in lipid profile, and hypoglycemia. Furthermore, the infection resulted in the upregulation of interleukin-1β (IL-1β) and interleukin-6 (IL-6), alongside the downregulation of transforming growth factor-beta (TGF-β) and interleukin-10 (IL-10) gene expression levels. The pathological lesions in the splenic and brain tissues, coupled with a significant increase in brain acetylcholinesterase (AChE) activity and oxidative stress, were also observed in the infected groups. Cichorium intybus fraction administration significantly reduced the parasitemia level and alleviated the pathological changes caused by T. evansi compared to the untreated infected group. The sesquiterpene lactones- enriched fraction from C. intybus demonstrates a notable anti-trypanosomal efficacy and may represent a promising source for the development of novel trypanocidal compounds.
- Open Access
- 1 July 2025
- Published by Egyptian Knowledge Bank in Assiut Veterinary Medical Journal
- Vol. 71 (186) , 507-522
ACUTE TOXICITY STUDY OF SESQUITERPENE LACTONES-ENRICHED FRACTION OF CICHORIUM INTYBUS IN RATS
Cichorium intybus has a wide range of therapeutic uses. This study aimed to investigate the acute toxic effect of the sesquiterpene lactone-enriched fraction of C. intybus in Wistar rats, following the Organization for Economic Cooperation and Development (OECD) Guideline 423. Thirty healthy female rats were divided equally into three groups. The first one was control. The second and third groups received a single dose of chicory fraction 2000 and 3000 mg/kg b.wt., respectively. In the 1st week after dosing, results showed a marked reduction in weight gain in both treated groups, with the death of 50% of the rats receiving 3000 mg/kg b.wt. Behavior test results revealed that chicory fraction at 2000 mg/kg b.wt. had a distinct anxiolytic effect and increased locomotor activity, while the highest dose of chicory fraction had anxiogenic action. Statistically significant leucopenia accompanied by absolute lymphopenia, with reduction in serum hepatic transaminase at both doses, has been noticed. Besides the haemato-biochemical alterations induced by chicory fraction, the hepatic tissues showed congestion and leucocytic infiltration, with eosinophilic reaction, especially with the highest dose. The renal tissue exhibited congestion and features of nephrosis in the form of vacuolation and hyaline droplets. In conclusion, the maximum safety dose of Cichorium intybus sesquiterpene lactones-enriched fraction is 2000 mg/kg b.wt. as it has an anxiolytic effect. While the higher dose (3000 mg/kg b.wt.) has an anxiogenic effect, 50% mortality of rats, indicating a marked toxicological effect. Key words: Cichorium intybus, sesquiterpene lactones, toxicity, rats.
- 1 July 2025
- Published by Egyptian Knowledge Bank in Assiut Veterinary Medical Journal
- Vol. 71 (186) , 507-522
Open AccessACUTE TOXICITY STUDY OF SESQUITERPENE LACTONES-ENRICHED FRACTION OF CICHORIUM INTYBUS IN RATS
Cichorium intybus has a wide range of therapeutic uses. This study aimed to investigate the acute toxic effect of the sesquiterpene lactone-enriched fraction of C. intybus in Wistar rats, following the Organization for Economic Cooperation and Development (OECD) Guideline 423. Thirty healthy female rats were divided equally into three groups. The first one was control. The second and third groups received a single dose of chicory fraction 2000 and 3000 mg/kg b.wt., respectively. In the 1st week after dosing, results showed a marked reduction in weight gain in both treated groups, with the death of 50% of the rats receiving 3000 mg/kg b.wt. Behavior test results revealed that chicory fraction at 2000 mg/kg b.wt. had a distinct anxiolytic effect and increased locomotor activity, while the highest dose of chicory fraction had anxiogenic action. Statistically significant leucopenia accompanied by absolute lymphopenia, with reduction in serum hepatic transaminase at both doses, has been noticed. Besides the haemato-biochemical alterations induced by chicory fraction, the hepatic tissues showed congestion and leucocytic infiltration, with eosinophilic reaction, especially with the highest dose. The renal tissue exhibited congestion and features of nephrosis in the form of vacuolation and hyaline droplets. In conclusion, the maximum safety dose of Cichorium intybus sesquiterpene lactones-enriched fraction is 2000 mg/kg b.wt. as it has an anxiolytic effect. While the higher dose (3000 mg/kg b.wt.) has an anxiogenic effect, 50% mortality of rats, indicating a marked toxicological effect. Key words: Cichorium intybus, sesquiterpene lactones, toxicity, rats.
- Open Access
- 27 June 2025
- Published by Springer Nature in BMC Veterinary Research
- Vol. 21 (1) , 1-15
Antitrypanosomal potential of Salvia officinalis terpenoids-rich fraction in Trypanosoma evansi-infected rat model
Background Trypanosoma evansi: (T. evansi) is a major protozoan disease that affects animals, including camels, and causes substantial economic detriments. The failure to control T. evansi infections is due to the unavailability of vaccines and the development of resistance to existing chemical drugs. In this study, we evaluated the effect of Salvia officinalis terpenoids-rich fraction on the degree of parasitemia and associated pathological alterations in rats experimentally infected with T. evansi. Method: Eighty adult male rats were equally divided into 4 groups. The first group was a negative control. The second group was intraperitoneally infected with T. evansi at a dose of 1 × 104 trypanosomes. The third group was similarly infected and subsequently treated intramuscularly with diminazene aceturate at a dose of 7 mg/kg body weight (b.wt.). The fourth group received a daily oral administration of Salvia officinalis terpenoids-rich fraction at a dose of 300 mg/kg b.wt. throughout the experimental period and was also infected with T. evansi. Result: The infection with T. evansi resulted in normocytic normochromic anemia, leukocytosis, hypoglycemia, hypertriglyceridemia, an increase in very low-density lipoprotein (VLDL) cholesterol, and reductions in high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterols. Additionally, the infection induced upregulation of the pro-inflammatory cytokines such as interleukin-1beta (IL-1β) and interleukin-6 (IL-6), and downregulation of the anti-inflammatory cytokines such as interleukin-10 (IL-10) and transforming growth factor beta (TGF-β). Besides histopathological changes in the brain and spleen, T. evansi markedly elevated brain oxidative stress and acetylcholinesterase (AChE) activity. The treatment with salvia fraction significantly decreased the degree of parasitemia and mitigated the T. evansi–induced pathological alterations. Conclusion: The terpenoids-rich fraction from Salvia officinalis exhibits antitrypanosomal activity and may serve as a promising candidate for developing novel trypanocidal agents.
- 27 June 2025
- Published by Springer Nature in BMC Veterinary Research
- Vol. 21 (1) , 1-15
Open AccessAntitrypanosomal potential of Salvia officinalis terpenoids-rich fraction in Trypanosoma evansi-infected rat model
Background Trypanosoma evansi: (T. evansi) is a major protozoan disease that affects animals, including camels, and causes substantial economic detriments. The failure to control T. evansi infections is due to the unavailability of vaccines and the development of resistance to existing chemical drugs. In this study, we evaluated the effect of Salvia officinalis terpenoids-rich fraction on the degree of parasitemia and associated pathological alterations in rats experimentally infected with T. evansi. Method: Eighty adult male rats were equally divided into 4 groups. The first group was a negative control. The second group was intraperitoneally infected with T. evansi at a dose of 1 × 104 trypanosomes. The third group was similarly infected and subsequently treated intramuscularly with diminazene aceturate at a dose of 7 mg/kg body weight (b.wt.). The fourth group received a daily oral administration of Salvia officinalis terpenoids-rich fraction at a dose of 300 mg/kg b.wt. throughout the experimental period and was also infected with T. evansi. Result: The infection with T. evansi resulted in normocytic normochromic anemia, leukocytosis, hypoglycemia, hypertriglyceridemia, an increase in very low-density lipoprotein (VLDL) cholesterol, and reductions in high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterols. Additionally, the infection induced upregulation of the pro-inflammatory cytokines such as interleukin-1beta (IL-1β) and interleukin-6 (IL-6), and downregulation of the anti-inflammatory cytokines such as interleukin-10 (IL-10) and transforming growth factor beta (TGF-β). Besides histopathological changes in the brain and spleen, T. evansi markedly elevated brain oxidative stress and acetylcholinesterase (AChE) activity. The treatment with salvia fraction significantly decreased the degree of parasitemia and mitigated the T. evansi–induced pathological alterations. Conclusion: The terpenoids-rich fraction from Salvia officinalis exhibits antitrypanosomal activity and may serve as a promising candidate for developing novel trypanocidal agents.
- Open Access
- 1 January 2025
- Published by Egyptian Knowledge Bank in Assiut Veterinary Medical Journal
- Vol. 71 (184) , 386-400
ACUTE SAFETY STUDY OF SALVIA OFFICINALIS TERPENOIDS RICH FRACTION IN WISTAR RATS
Salvia plants become more popular due to their health-promoting and antioxidant potential. The present study aimed to investigate the safety limit of Salvia officinalis terpenoids-rich fraction in Wistar rats. Thirty adult female rats were divided equally into three groups. The first one was control. The second and third groups received Salvia fraction as a single oral dose of 2 and 3 g/kg b.w., respectively. During the experimental period, any abnormal clinical signs, morbidity and mortality rates, as well as weekly body weight gain were recorded. At the end of the experiment, behavior tests were performed and blood specimens were collected for hematological and biochemical examinations. The liver and kidney were collected for histopathology. There were no abnormal variations in clinical signs or weight gain at both doses. Salvia fraction at both doses had a distinct anxiolytic effect; however, it improved working memory only at the 2 g/kg b.w. group. There was an increment in locomotor activity in rats receiving 3 g/kg b.w. For hematology and clinical biochemistry, there was mild leucopenia accompanied by absolute lymphopenia and a decrease in ALT and AST activities in rats receiving 3 g/kg b.w. of Salvia fraction, besides no significant change in urea and creatinine in both treated groups. In conclusion, the Salvia officinalis terpenoids-rich fraction appears to have no adverse toxic effects, except for minimal alterations in leucogram, liver enzymes, and hepatic and renal tissues induced in rats treated with 3 g/kg b.w, of the Salvia fraction. Key words: Salvia officinalis, terpenoids, safety, rats.
- 1 January 2025
- Published by Egyptian Knowledge Bank in Assiut Veterinary Medical Journal
- Vol. 71 (184) , 386-400
Open AccessACUTE SAFETY STUDY OF SALVIA OFFICINALIS TERPENOIDS RICH FRACTION IN WISTAR RATS
Salvia plants become more popular due to their health-promoting and antioxidant potential. The present study aimed to investigate the safety limit of Salvia officinalis terpenoids-rich fraction in Wistar rats. Thirty adult female rats were divided equally into three groups. The first one was control. The second and third groups received Salvia fraction as a single oral dose of 2 and 3 g/kg b.w., respectively. During the experimental period, any abnormal clinical signs, morbidity and mortality rates, as well as weekly body weight gain were recorded. At the end of the experiment, behavior tests were performed and blood specimens were collected for hematological and biochemical examinations. The liver and kidney were collected for histopathology. There were no abnormal variations in clinical signs or weight gain at both doses. Salvia fraction at both doses had a distinct anxiolytic effect; however, it improved working memory only at the 2 g/kg b.w. group. There was an increment in locomotor activity in rats receiving 3 g/kg b.w. For hematology and clinical biochemistry, there was mild leucopenia accompanied by absolute lymphopenia and a decrease in ALT and AST activities in rats receiving 3 g/kg b.w. of Salvia fraction, besides no significant change in urea and creatinine in both treated groups. In conclusion, the Salvia officinalis terpenoids-rich fraction appears to have no adverse toxic effects, except for minimal alterations in leucogram, liver enzymes, and hepatic and renal tissues induced in rats treated with 3 g/kg b.w, of the Salvia fraction. Key words: Salvia officinalis, terpenoids, safety, rats.
- 15 January 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 163, 105410
The modulatory effect of carvacrol on viral shedding titer and acute phase response in broiler chickens experimentally infected with infectious bronchitis virus
- 15 January 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 163, 105410
The modulatory effect of carvacrol on viral shedding titer and acute phase response in broiler chickens experimentally infected with infectious bronchitis virus